Drug Type Small molecule drug |
Synonyms NEOZOLE |
Target |
Action agonists, inhibitors |
Mechanism GR agonists(Glucocorticoid receptor agonists), fungal CYP51A1 inhibitors(Fungal CYP51A1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Australia (10 Jun 2026), |
Regulation- |
Molecular FormulaC21H30O5 |
InChIKeyJYGXADMDTFJGBT-VWUMJDOOSA-N |
CAS Registry50-23-7 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Candidiasis | Australia | 10 Jun 2026 | |
| Dermatomycoses | Australia | 10 Jun 2026 | |
| Diaper Rash | Australia | 10 Jun 2026 | |
| Intertrigo | Australia | 10 Jun 2026 | |
| Yeast infection of the skin | Australia | 10 Jun 2026 |





